Entacapone News

Entacapone currently has 3 news articles, with 20 predicted indications.

This page combines the AI-predicted indications for Entacapone with the latest health news. Indications highlighted in orange have recent news coverage.

Drug Information

Original indication: Entacapone is indicated as an adjunct to standard preparations of levodopa / benserazide or levodopa / carbidopa for use in adult patients with Parkinson's disease and end-of-dose motor fluctuations,...
Evidence level: L5
Predicted indications (20):
- juvenile onset Parkinson disease 19A (100.0%)
- hereditary late onset Parkinson disease (99.9%)
- atypical juvenile parkinsonism (99.8%)
- X-linked parkinsonism-spasticity syndrome (99.8%)
- PLA2G6-associated neurodegeneration (99.8%)
- Rasmussen subacute encephalitis (99.7%)
- Parkinson disease (99.7%)
- myelitis (99.6%)
- paralysis agitans, juvenile, of Hunt (99.6%)
- parkinsonian-pyramidal syndrome (99.5%)
- hemiparkinsonism-hemiatrophy syndrome (99.5%)
- transaldolase deficiency (99.4%)
- early-onset parkinsonism-intellectual disability syndrome (99.3%)
- lethal infantile mitochondrial myopathy (99.3%)
- Lewy body dementia (99.2%)
- fructose-1,6-bisphosphatase deficiency (99.2%)
- polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis (99.1%)
- progressive supranuclear palsy-corticobasal syndrome (99.0%)
- X-linked intellectual disability-ataxia-apraxia syndrome (99.0%)
- congenital disorder of glycosylation with defective fucosylation (98.9%)